|  | Breast cancer | Prostate cancer | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | HR | SE | p | 95% CI | N | HR | SE | p | 95% CI | ||
Model A | BPA levels (for 5 ng/ml increase) | 2306 | 1.047 | 0.037 | 0.200 | 0.98–1.12 | 2328 | 0.989 | 0.036 | 0.749 | 0.92–1.06 |
Model B | log2(BPA) | 2306 | 1.011 | 0.024 | 0.655 | 0.97–1.06 | 2328 | 1.035 | 0.021 | 0.093 | 0.99–1.08 |
Model C | Categorized BPA (values in ng/ml) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
<LOD | 705 | 1 | – | – | – | 658 | 1 | – | – | – | |
Tertile 1 [0.2–1.8) | 562 | 0.820 | 0.123 | 0.185 | 0.61–1.10 | 534 | 1.404 | 0.208 | 0.022 | 1.05–1.88 | |
Tertile 2 [1.8–5.1) | 556 | 0.875 | 0.132 | 0.376 | 0.65–1.18 | 540 | 1.365 | 0.200 | 0.034 | 1.02–1.82 | |
Tertile 3 [5.1–68.9] | 483 | 1.127 | 0.169 | 0.425 | 0.84–1.51 | 596 | 1.305 | 0.193 | 0.072 | 0.98–1.74 |